Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Current Deferred Revenue (2016 - 2021)

Milestone Scientific's Current Deferred Revenue history spans 7 years, with the latest figure at $407050.0 for Q3 2021.

  • For Q3 2021, Current Deferred Revenue rose 19.55% year-over-year to $407050.0; the TTM value through Sep 2021 reached $407050.0, up 19.55%, while the annual FY2020 figure was $242589.0, 28.75% down from the prior year.
  • Current Deferred Revenue for Q3 2021 was $407050.0 at Milestone Scientific, up from $337145.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $2.8 million in Q2 2018 and bottomed at $50000.0 in Q1 2019.
  • The 5-year median for Current Deferred Revenue is $356400.0 (2017), against an average of $576287.5.
  • The largest annual shift saw Current Deferred Revenue plummeted 97.1% in 2019 before it surged 580.95% in 2020.
  • A 5-year view of Current Deferred Revenue shows it stood at $751500.0 in 2017, then plummeted by 86.69% to $100000.0 in 2018, then surged by 240.48% to $340476.0 in 2019, then decreased by 28.75% to $242589.0 in 2020, then soared by 67.79% to $407050.0 in 2021.
  • Per Business Quant, the three most recent readings for MLSS's Current Deferred Revenue are $407050.0 (Q3 2021), $337145.0 (Q2 2021), and $241288.0 (Q1 2021).